Table 1.
Baseline demographic data in HIV-infected children with NP specimens
| Patients N = 203 | |
| Female | 96 (47.3%) |
| Median age (IQ range) | 1.8 (0.7 – 4) years |
| CDC Clinical Class | |
| N | 2 (0.9%) |
| A | 17 (8.4%) |
| B | 138 (68%) |
| C | 46 (22.7%) |
| CDC Immunological | |
| 1 | 44 (22%) |
| 2 | 85 (42.5%) |
| 3 | 71 (35.5%) |
| CD4 percentage | 19 (14 – 26) |
| Hospitalization | |
| None in past | 52 (25.6%) |
| 1 | 54 (26.6%) |
| 2 | 53 (26.11%) |
| 3 | 28 (13.79%) |
| 4 | 11 (5.42%) |
| 5 | 5 (2.46%) |
| Recruited to study during or immediately after current hospitalization | 91 (44.8%) |
| No hospitalization | 38 (18.7%) |
| TMP-SMX status | |
| No previous experience | 47 (23.3%) |
| On drug at baseline | 141 (69.8) |
| History of exposure | 15 (7.4%) |
| Median weight for age Z-score (IQ range) | -1.6 (-3 – -0.4) |
| Antiretroviral therapy at baseline | 19 (9.4%) |
| Time on therapy | 0.5 (0.2 – 1.1) years |
| Died within 12 months of enrolment | 35 (17.2%) |